โ๏ธ [Startup presentation] Today, meet Emilia McLaughlin โ co-founder at kyron.bio for more effective therapeutics! ๐ซ๐ท๐
Based at the PC’UP – Incubateur ESPCI Paris in the heart of Paris, kyron.bio’s mission is to deliver safer and more effective therapeutics to patients by using sugar molecules – also known as glycans – to sculpt the surface of a drug. This is the first time that precision control of sugars has been harnessed in drug design, and opens up a wealth of opportunities for new therapeutics.
๐ช๐ผ ๐ง๐ต๐ฒ ๐ธ๐๐ฟ๐ผ๐ป.๐ฏ๐ถ๐ผ ๐๐ฒ๐ฎ๐บ ๐๐ฝ๐ถ๐ฟ๐ถ๐ : eating together and sharing, as a well-nourished team is a productive team!
๐ฑ ๐ช๐ฎ๐ ๐ผ๐ณ ๐น๐ถ๐ณ๐ฒ : passionate, energetic and always up for an adventure, Emilia shows interest in nature and horse riding as well as sheโs also a creative at heart, often found at the pottery studio or a yoga class
๐ ๐ช๐ต๐ ๐ฃ๐’๐จ๐ฃ? Being integrated at PCโUP offered us much more than a workspace; it has been our company home for the past years. We have created a strong network with the other startups. Beyond this, being located within the ESPCI Paris – PSL ecosystem has been an enormous help, enabling us to access expertise as well as top academic teams and platforms. This collaborative environment allows us to access a wealth of resources and equipment, providing everything we need and more to advance our projects effectively.